Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Per Thor Straten

Showing results (101-110 of 171) with videos related to

Pageof 18
Sort By:
Frontiers in Immunology|December 13, 2021
Mitochondrial-Linked <i>De Novo</i> Pyrimidine Biosynthesis Dictates Human T-Cell Proliferation but Not Expression of Effector MoleculesMarlies J W Peeters, Pia Aehnlich, Adriano Pizzella, et al.
Plos One|April 28, 2012
Natural CD4+ T-cell responses against indoleamine 2,3-dioxygenaseShamaila Munir, Stine Kiaer Larsen, Trine Zeeberg Iversen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 19, 2009
CD8 T-cell responses against cyclin B1 in breast cancer patients with tumors overexpressing p53Rikke Baek Sørensen, Rikke Sick Andersen, Inge Marie Svane, et al.
European Journal of Haematology|August 2, 2014
Expansion of circulating CD56bright natural killer cells in patients with JAK2-positive chronic myeloproliferative neoplasms during treatment with interferon-αCaroline H Riley, Morten Hansen, Marie K Brimnes, et al.
Cancers|December 23, 2023
Preferential Expansion of HPV16 E1-Specific T Cells from Healthy Donors' PBMCs after Ex Vivo Immunization with an E1E2E6E7 Fusion AntigenJoana Daradoumis, Mikkel Dons Müller, Patrick Neckermann, et al.
Cytotherapy|June 17, 2009
Longitudinal immune monitoring of patients receiving intratumoral injection of a MART-1 T-cell receptor-transduced cell line (C-Cure 709)Tania Køllgaard, Lone Duval, Henrik Schmidt, et al.
Cancer Immunology, Immunotherapy : CII|July 8, 2005
Identification of identical TCRs in primary melanoma lesions and tumor free corresponding sentinel lymph nodesPer thor Straten, Christina Dahl, David Schrama, et al.
International Journal of Cancer|March 25, 2006
Tumor infiltrating lymphocytes in seminoma lesions comprise clonally expanded cytotoxic T cellsSine Reker Hadrup, Otto Braendstrup, Grete Krag Jacobsen, et al.
Oncoimmunology|October 21, 2016
mRNA-transfected dendritic cell vaccine in combination with metronomic cyclophosphamide as treatment for patients with advanced malignant melanomaTroels Holz Borch, Lotte Engell-Noerregaard, Trine Zeeberg Iversen, et al.
Cytotherapy|May 22, 2024
Glycolysis inhibition affects proliferation and cytotoxicity of Vγ9Vδ2 T cells expanded for adoptive cell therapyPia Aehnlich, Marta Velasco Santiago, Søren Helweg Dam, et al.
Pageof 18

Showing results (101-110 of 171) with videos related to

Sort By:
Pageof 18
Frontiers in Immunology|December 13, 2021
Mitochondrial-Linked <i>De Novo</i> Pyrimidine Biosynthesis Dictates Human T-Cell Proliferation but Not Expression of Effector MoleculesMarlies J W Peeters, Pia Aehnlich, Adriano Pizzella, et al.
Plos One|April 28, 2012
Natural CD4+ T-cell responses against indoleamine 2,3-dioxygenaseShamaila Munir, Stine Kiaer Larsen, Trine Zeeberg Iversen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 19, 2009
CD8 T-cell responses against cyclin B1 in breast cancer patients with tumors overexpressing p53Rikke Baek Sørensen, Rikke Sick Andersen, Inge Marie Svane, et al.
European Journal of Haematology|August 2, 2014
Expansion of circulating CD56bright natural killer cells in patients with JAK2-positive chronic myeloproliferative neoplasms during treatment with interferon-αCaroline H Riley, Morten Hansen, Marie K Brimnes, et al.
Cancers|December 23, 2023
Preferential Expansion of HPV16 E1-Specific T Cells from Healthy Donors' PBMCs after Ex Vivo Immunization with an E1E2E6E7 Fusion AntigenJoana Daradoumis, Mikkel Dons Müller, Patrick Neckermann, et al.
Cytotherapy|June 17, 2009
Longitudinal immune monitoring of patients receiving intratumoral injection of a MART-1 T-cell receptor-transduced cell line (C-Cure 709)Tania Køllgaard, Lone Duval, Henrik Schmidt, et al.
Cancer Immunology, Immunotherapy : CII|July 8, 2005
Identification of identical TCRs in primary melanoma lesions and tumor free corresponding sentinel lymph nodesPer thor Straten, Christina Dahl, David Schrama, et al.
International Journal of Cancer|March 25, 2006
Tumor infiltrating lymphocytes in seminoma lesions comprise clonally expanded cytotoxic T cellsSine Reker Hadrup, Otto Braendstrup, Grete Krag Jacobsen, et al.
Oncoimmunology|October 21, 2016
mRNA-transfected dendritic cell vaccine in combination with metronomic cyclophosphamide as treatment for patients with advanced malignant melanomaTroels Holz Borch, Lotte Engell-Noerregaard, Trine Zeeberg Iversen, et al.
Cytotherapy|May 22, 2024
Glycolysis inhibition affects proliferation and cytotoxicity of Vγ9Vδ2 T cells expanded for adoptive cell therapyPia Aehnlich, Marta Velasco Santiago, Søren Helweg Dam, et al.
Pageof 18